Instrument Launches, Small-Molecule Techniques and Kool-Aid as PITTCON Philadelphia Begins

Pittcon 2019 now in its 70th year, meets in Philadelphia this week.  The meeting is an opportunity to showcase improvements in laboratory technology.  While mass spectrometry and liquid chromatography are key areas for vendors, this year’s meeting will feature a large demonstration space where vendors will show off spectrometry, software and even analyze common everyday […]

READ MORE..


What Does The “Second Wave” of 2018/19 Flu Season Mean for IVD Markets?

The CDC reports a late peak and possible second wave to what was previously thought to be a weaker flu season compared to recent years. This is important for IVD makers, as respiratory IVD markets are driven to a great extent by the severity of the flu season. While the total number of cases remains […]

READ MORE..


New Report Details $350 Billion Industry That No One Dominates

Kalorama Information’s new report on U.S. long-term care, “The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living,” finds that growth will be fueled by the diversity of services that can be offered. The industry will near the half-trillion dollar mark in the next five years, growing even with cautious payor […]

READ MORE..


Innovations in Microbiology Testing

Detection of infectious disease promptly and accurately is important because the burden of infectious disease is high.  In the United States, chronic lower respiratory diseases were the third leading cause of death in 2015, behind only heart disease and cancer.  The Center for Disease Control and Prevention (CDC) reports that 155,041 people died in the […]

READ MORE..


VA – Foundation Medicine Deal a Boon for Use of Liquid Biopsy/NGS in Cancer Diagnostics

News came this week that the Department of Veterans Affairs awarded Foundation Medicine, a Cambridge, MA- based molecular testing company, a significant contract to provide genomic profiling for veterans helps to validate the growing use of NGS and liquid biopsy for diagnostics. The contract was reported to be at 111.5 million over five years. It […]

READ MORE..


1.5 Billion Yet-Unclaimed Revenue in The LATAM IVD Market: Report

There is IVD sold almost everywhere in the world but revenue growth is not found everywhere. For most of the top IVD companies, adding scores of millions in growth would be helpful to business plans. That’s why growth regions such as Latin America offer promise beyond their market size. The maturation of IVD markets in developed countries (growth […]

READ MORE..

  • by Bruce Carlson
  • January 11, 2019
  • News


New CVS Hub Stores, NASH Drugs, Liquid Biopsy, Illumina Chip, Smokeless Tobacco Reduction, Among Developments at JPM and Biotech Showcase

The 2019 J.P. Morgan Healthcare Conference (JPM) has ended.  Nearly 500 companies from biotech, pharma, insurance, hospital systems and more gave investor presentations to more than 9,000 attendees at the Westin St. Francis hotel this year.  The size of the conference suggests that the decision as to what the investor conference and related product showcases […]

READ MORE..


Big Developments in DTC Testing Space

Two big developments in direct-to-consumer testing in October.  While one lab giant has teamed up with a major drugstore retailer to offer consumers the ability to test themselves at portals, another has opened it’s website to online tests.  We cover direct to consumer testing, routine and genetic, in our market research report on the topic. (https://www.kaloramainformation.com/Direct-Consumer-DTC-9588755/).  […]

READ MORE..


The Latest Developments in HIV Diagnostic Testing

HIV remains a deadly disease, but fortunately, in vitro diagnostic solutions abound for its detection and progress-tracking of treatments.  In this article, we chronicle the developments in HIV IVD – more information can be found in our Worldwide Market for In Vitro Diagnostics Tests, 11th Edition: https://www.kaloramainformation.com/Worldwide-In-Vitro-Diagnostic-Tests-11th-Edition-11723890/ Many of the 35.3 million people infected with HIV worldwide […]

READ MORE..


Where Clinical Sequencing Is Now

It has been little more than a year since the U.S. Food and Drug Administration (FDA) approved the first next generation sequencing (NGS) test for clinical use, and only a few months since the U.S. Centers for Medicare and Medicaid Services (CMS) announced it would provide national coverage for NGS tests for advanced cancer patients. […]

READ MORE..